Global Biotech News US Faces Shortage Of Drug Used To Treat Pediatric...

US Faces Shortage Of Drug Used To Treat Pediatric Cancers

-

US Cancer Drug Shortage

A critical drug that treats pediatric cancers is in low supply in the United States. Doctors are describing this situation as a “nightmare.”

Vincristine is used to treat common pediatric cancers such as leukemia, and lymphoma has become increasingly scarce after one of two manufacturers stopped its production in July.

On Friday, the US FDA announced supplies would be fully recovered by January 2020. Still, the medication is now on back-order, and doctors throughout the United States are facing the difficult decision of rationing the drug to their young and sick patients.

US Cancer Drug Shortage- A Major Problem

Dr. Yoram Unguru, a pediatric oncologist at the Herman and Walter Samuelson Children’s Hospital, said that vincristine is the critical drug used to treat pediatric cancer. He added that it is used in almost all child pediatric cancer treatment.

According to the American Childhood Cancer Organization, approximately 16,000 children are diagnosed with cancer in the US each year.

Dr. Michael Isakoff at Connecticut Children’s Medical Center in Hartford said his team treats up to 100 children diagnosed with cancer every year.

According to the US FDA, Teva, one of two manufacturers of the drug, discontinued the manufacture of vincristine earlier this year, consequently leaving Pfizer as the sole supplier of Vincristine in the United States.

READ  'Artificial Leaf' Successfully Produces 'Clean' Fuel

Manufacturing problems have led to a delay at Pfizer, therefore, the US Cancer Drug Shortage, the FDA said.

Pfizer, in a statement, said that they would expedite shipping of the drug in the coming weeks and ramp up production to four times what they typically made before Teva withdrew from the market.

READ  University of Cambridge PhD Studentship 2020-2021

US Cancer Drug Shortage would be resolved by 2020 according to the FDA.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

U.S. Just Signed $450 Million Coronavirus Vaccine Contract With J&J

The U.S. Authorized Coronavirus Vaccine Contract worth of 450 Million Dollar With Johnson & Johnson The Trump administration is investing...

Oxford University Begins Its Coronavirus Vaccine Clinical Trials On Humans

Oxford University Coronavirus Vaccine Clinical Trials on Humans Begins Based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein, Oxford...

Mesa Biotech Gets Emergency FDA Approval For Rapid COVID-19 Test

Mesa Biotech's Rapid Test For COVID-19 Gets Emergency FDA Approval  The Food and Drug Administration (FDA), U.S. is using its...

New Device To Detect Harmful Bacteria In Blood

New Device to Detect Bacteria in Blood Healthcare professionals can now pinpoint the cause of potentially deadly infections and can...

Amazon Care to provide delivery and pick-up of “At-Home COVID-19 Test Sample Kits” in Seattle trial

                             Home-delivery of COVID-19 Test Kits Amazon...

Treatment Trials for COVID-19 by Sanofi and Regeneron

Initial Treatment Trials for COVID-19 by Sanofi and Regeneron On 16 March 2020, Sanofi and Regeneron Pharmaceuticals Inc. stated that...

Must read

US Faces Shortage Of Drug Used To Treat Pediatric Cancers

US Cancer Drug Shortage A critical drug that treats pediatric...

Scientists Develop Fully Recyclable Plastics!

Fully Recyclable Plastics Developed Scientists at the Basque Country and...
- Advertisement -

You might also likeRELATED
Recommended to you